NCT04696172View on ClinicalTrials.gov

Plasma Biomarkers of Cardiopulmonary Bypass Induced Acute Respiratory Distress Syndrome (CPB-ARDS)

CompletedOBSERVATIONAL
Enrollment

525

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

July 30, 2022

Study Completion Date

August 30, 2022

Conditions
Acute Respiratory Distress Syndrome
Trial Locations (2)

430022

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Wuhan Asia Heart Hospital, Wuhan

All Listed Sponsors
collaborator

Wuhan Asia Heart Hospital

OTHER

lead

Huazhong University of Science and Technology

OTHER

NCT04696172 - Plasma Biomarkers of Cardiopulmonary Bypass Induced Acute Respiratory Distress Syndrome (CPB-ARDS) | Biotech Hunter | Biotech Hunter